Trial
NCT05264506
Contraceptive Efficacy and Safety of NOMAC-E2 Combined Oral Contraceptive
Phase IIITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Organon and Co
Collaborators
IQVIA Pty Ltd
Condition
Contraception
Intervention
NOMAC-E2 COC
Why stopped
Sponsor decision to stop the study early and complete all required study close-out activities. This decision was made for business reasons unrelated to safety. None of the pre-specified efficacy endpoints were analyzed.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-11-21